ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9%
Mon, 27 May

ASTRAZENECA PHARMA has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m1,5072,1521,903-11.6%26.3%
Other incomeRs m23356072.0%157.1%
TurnoverRs m1,5312,1871,963-10.2%28.3%
ExpensesRs m1,3551,7431,8395.5%35.8%
Gross profitRs m15340964-84.4%-58.3%
DepreciationRs m3638393.4%10.1%
InterestRs m0000.0%0.0%
Profit before taxRs m14140685-79.1%-39.7%
TaxRs m108115-14-111.7%-112.5%
Profit after taxRs m3229198-66.2%204.9%
Gross profit margin%10.119.03.3
Effective tax rate%77.128.3-15.9
Net profit margin%2.113.35.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 26.3% on a year-on-year (YoY) basis. The expenses were up by 35.8% YoY during the same period.
  • The company's operating profit declined by 58.3% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 3.3% in 4QFY19 as against 10.1% in 4QFY18.
  • Depreciation charges increased by 10.1% and finance costs increased by 0.0% YoY, respectively.
  • Other income increased by 157.1% YoY during the quarter.
  • Net profit for the quarter increased by 204.9% YoY. Net profit margins during the quarter increased from 2.1% in 4QFY18 to 5.0% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 11.6% on a quarter-on-quarter (QoQ) basis. The expenses were up by 5.5% QoQ during the same period.
  • The company's operating profit declined by 84.4% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 3.3% in 4QFY19 as against 19.0% in 3QFY18.
  • Net profit for the quarter declined by 66.2% QoQ, while net profit margins declined from 13.3% in 3QFY18 to 5.0% in 4QFY19.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters, please visit here.

ASTRAZENECA PHARMA Share Price Performance

Over the last one year, ASTRAZENECA PHARMA share price has moved up from Rs 1,194.6 to Rs 2,089.9, registering a Gain of Rs 895.4 or around 75.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,392.0 (down 0.0%). Over the last one year it has moved up from 13,044.2 to 13,392.0, a gain of 348 points (up 2.7%).

Overall, the S&P BSE SENSEX is up 14.3% over the year.

Current Valuations

At the current price of Rs 2,089.9, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 96.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 21.2 times.

Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9%". Click here!

  

Related Views on News

ASTRAZENECA PHARMA Surges by 5%; BSE HEALTHCARE Index Up 0.6% (Market Updates)

Jan 28, 2020 | Updated on Jan 28, 2020

ASTRAZENECA PHARMA share price has surged by 5% and its current market price is Rs 2,692. The BSE HEALTHCARE is up by 0.6%. The top gainers in the BSE HEALTHCARE Index are ASTRAZENECA PHARMA (up 5.4%) and SUN PHARMA ADV. RES. (up 5.1%). The top losers are BLISS GVS PHARMA (down 0.1%) and JUBILANT LIFE SCIENCES (down 0.1%).

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 381.0% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ASTRAZENECA PHARMA has posted a net profit of Rs 291 m (up 381.0% YoY). Sales on the other hand came in at Rs 2 bn (up 67.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

How to Buy the Best Safe Stocks in 2020(The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market(Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys(The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

The Best Asset Class to Invest in 2020(Fast Profits Daily)

Jan 24, 2020

Why I'm most bullish on this asset class above all else in 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


Jan 28, 2020 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - MYLAN COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS